Search
for
Sort by
Research 181–210 of 657
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Management of Toxicities of Targeted Therapies
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Lab Quality Management and Methodology
- A comment on a study of donor area in follicular unit hair transplantation
- Cytostatics and immunosuppressive drugs
- Hair Disorders
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Menopause and aging, quality of life and sexuality
- New approaches to the treatment of osteoporosis
- Prescribing testosterone and DHEA: The role of androgens in women
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Antiandrogen Therapy for Skin and Hair Disease
- Clinical manifestations of polycystic ovary syndrome
- Androgens in SARS-CoV-2 Coronavirus Infections
- Ottawa, Ontario, Canada, February 13–16, 2013
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Reporting on Adverse Clinical Events
- Complications in Esthetic Surgery
- COVID-19 and Sex Differences
- Cutaneous Lupus Erythematosus
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature